About Actorius Innovations and Research Private Limited
Data last updated:
Actorius Innovations and Research Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 14 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2013PTC246961. Its GSTIN is 27AALCA8824E1ZJ (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.63 Lakh. It is led by directors including Rakshit Shriram Kamble and Jayant Jagannath Khandare.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 203 2nd Floor 6 Mhada Delux Flats Rambaug A.S Marg Powai, Mumbai, Maharashtra, India – 400076.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.47 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹2 Cr (net margin -135.4%) and EBITDA of -₹1.62 Cr (EBITDA margin -110.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 159% over five years.
The company is associated with 2 brands: OncoDiscover and Actorius.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website actorius.co.
Company details
Contact details
Actorius Innovations and Research Private Limited's registered office is in Mumbai, Maharashtra. Its website is actorius.co. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address203 2nd Floor 6 Mhada Delux Flats Rambaug A.S Marg Powai, Mumbai, Maharashtra, India – 400076
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Actorius Innovations and Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Actorius Innovations and Research operates two associated brands: OncoDiscover and Actorius. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers a blood-based CTC test for cancer detection, monitoring, and therapy decisions. | oncodiscover.com | |
| Genomics-based diagnostic tests for cancer are developed. | actorius.co |
Business activity
The main business activity of Actorius Innovations and Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Actorius Innovations and Research Private Limited, buy the company report.
Financials of Actorius Innovations and Research Private Limited
FY 2024 filings availableActorius Innovations and Research Private Limited reported revenue of ₹1.47 Cr (down 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 159%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.62 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -110.2% | ||||
| Net Profit Margin | -135.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Actorius Innovations and Research Private Limited, buy the company report.
Board of directors of Actorius Innovations and Research Private Limited
Actorius Innovations and Research has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakshit Shriram Kamble | Director | 15 Sep 2020 | 6 Years 1 Months | Current |
| Jayant Jagannath Khandare Also directs: Precision Oncology Foundation, Foodoscope Technologies Private Limited, Admatius Innovations Private Limited and 3 more | Director | 14 Aug 2013 | 13 Years 2 Months | Current |
| Aravindan Vasudevan Also directs: Precision Oncology Foundation | Director | 14 Aug 2013 | 13 Years 2 Months | Current |
Auditor
Actorius Innovations and Research Private Limited is audited by MANOJ KOCHAR & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ KOCHAR & COMPANY | FY 2023 | 143052W |
Shareholding
The shareholding of Actorius Innovations and Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Actorius Innovations and Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Actorius Innovations and Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Actorius Innovations and Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Actorius Innovations and Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCA8824E1ZJ | Maharashtra | Active | 19 Sep 2017 |
To see the full GST registrations and return filing status of Actorius Innovations and Research Private Limited, buy the company report.
Recent activity
Actorius Innovations and Research Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Rakshit Shriram Kamble was appointed as Director on 15 Sep 2020.
Frequently asked questions
Actorius Innovations and Research is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 14 August 2013 (13+ years old) and is registered under CIN U73100MH2013PTC246961.
Actorius Innovations and Research has 3 current directors:
- Rakshit Shriram Kamble - Director
- Jayant Jagannath Khandare - Director
- Aravindan Vasudevan - Director
The latest financial statements of Actorius Innovations and Research on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Actorius Innovations and Research is 27AALCA8824E1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Actorius Innovations and Research is U73100MH2013PTC246961. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Actorius Innovations and Research was incorporated on 14 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Rakshit Shriram Kamble was appointed as Director on 15 Sep 2020. Murlidhara Padigaru ceased to be Director on 08 Aug 2018. Aravindan Vasudevan was appointed as Director on 14 Aug 2013. Actorius Innovations and Research has 4 board changes on record in total.
Actorius Innovations and Research can be reached through the website actorius.co. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Actorius Innovations and Research is at 203 2nd Floor 6 Mhada Delux Flats Rambaug A.S Marg Powai, Mumbai, Maharashtra, India – 400076.
Actorius Innovations and Research operates in the pharma industry, in the pharma contract r and d segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
